Cel Sci Corporation (CVM)

[Spideyboy]

I would understand the concern on lack of unlocked patient data, but double-blind studies are generally designed just like that, you wait till the end and unlock the sequence. A study sample is decided based on the power to determine outcome. If you stopped in between anyway, you may very well bias up or down due to the fact the sample isn't at the power to statistically show anything.

Also, if it was giving them a third eye or something else radical, I don't think the physicians would have had as high an enrollment (prior to hold at 928) and the CRO wouldn't have upped their investment.

CVM might be using their double-blind design as a shield to hide behind, which the only reason for that would be to enrich themselves while knowingly leaving the investors out to dry, which if a CVM investor feels this way, then my first move would be to sell immediately.

I personally don't feel that is the case. I just feel we have a management that needs to get things right and get things in perspective vis-a-vis obligations to shareholders. Their mess with the listing is due to having a relatively frivolous view of going to capital markets again and again, like it wasn't a problem. I remember not being impressed a couple years ago when Geert mentioned at an Investor Conference how he didn't understand why people sell after the company raises dilutive capital, as his perspective is that getting the money to proceed is all that is important. Anyway, not I'm on a tangent, but just as an example.

Point is I feel the key issue is under-performing management with a potential for a game changing product and if it were to be a new SOC, then we are talking huge returns. I do not however see a malicious management (which I have seen in other investments before), or I wouldn't be here.

Just my two cents